Skip to content

Evaluation of Adhesion Properties in Wound Care Devices

Evaluation of Adhesion Properties in Wound Care Devices

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06392165
Enrollment
20
Registered
2024-04-30
Start date
2024-04-24
Completion date
2025-06-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adhesion Properties of Wound Care Devices

Brief summary

Molnlycke manufactures and markets self-adhesive wound care devices intended to protect various types of wounds during treatment. This study aims to measure and evaluate the adhesion properties of self-adhesive wound care devices. To measure the adhesion properties test strips will be applied to the participant's skin for a predetermined time and will be removed while measuring the adhesion properties afterwards. This method has been chosen since there is no in vitro method available that can simulate adhesion to human skin

Interventions

OTHERself-adhesive device

Test device which is self-adhesive

Sponsors

Molnlycke Health Care AB
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Masking description

all participants will receive the same up to 12 test samples, which are randomized intra-individual.

Intervention model description

intra-individual test with up 12 test samples per study run; this treatment is announced here as single group study.

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
Yes

Inclusion criteria

* Confirmed eligibility and signed consent form.

Exclusion criteria

* Known plaster allergy or other known contact hypersensitivity * Pregnant or breastfeeding individual.

Design outcomes

Primary

MeasureTime frameDescription
Peel Off Forceup to 48 hoursInternal machine shall measure the peel force expressed in Newton.

Secondary

MeasureTime frameDescription
Humidityup to 48 hoursHumidity shall be evaluated using tactile and visual assessment
Rednessup to 48 hoursVisual assessment of redness of the skin
Pain assessmentup to 48 hoursVisual analog scale (VAS) assessment of pain after removal. The scale is 100mm long whether 0mm means no pain and 100mm means the maximum pain a participant could imagine.

Other

MeasureTime frameDescription
Looseningup to 48 hoursAssessment if the device is still in place or has been fallen of.
Commentsup to 48 hoursFurther comments (not related to the other outcomes) by the participant or the investigator
Adhesive residualsup to 48 hoursAdhesive residuals on the skin

Countries

Sweden

Contacts

Primary ContactMatthew Malone, PhD
matthew.malone@molnlycke.com+44 7977815953

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026